Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sinopharm to Acquire 80% of Aurobindo’s China Subsidiary

publication date: Jan 11, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China National Pharmaceutical Group Corporation (Sinopharm) will purchase 80% of an Aurobindo Pharma subsidiary in China. Aurobindo is an Indian generic pharmaceutical company, and its China subsidiary makes 6-APA, a derivative of Penicillin-G that Aurobindo uses for its own antibiotic products, which are manufactured in India. More details....

Stock Symbol: (SH: 600511)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors